Strategies to Account for Design Misspecifications in Randomized Controlled Trials.
Where this comes from
- Record sourced from PubMed, PMID 38319209.
- Also identified by DOI 10.1056/EVIDe2200012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mortality rates of infants (younger than 1 year of age) and neonates (younger than 1 month of age) remain unacceptably high in some geographic regions.<sup>1,2</sup> After the first week of life, infection is a significant cause of neonatal and postneonatal mortality.<sup>3,4</sup> Biannual mass azithromycin administration has been shown to reduce all-cause childhood mortality by as much as 25% among infants 1 to 5 months of age in Niger.<sup>5</sup>.